TE
Tema ETFs Portfolio holdings
AUM
$377M
This Quarter Return
-1.1%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$241M
AUM Growth
–
Cap. Flow
+$241M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
27.78%
Holding
148
New
148
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Rockwell Automation
ROK
|
$9.12M |
| 2 |
Applied Industrial Technologies
AIT
|
$8.13M |
| 3 |
Primoris Services
PRIM
|
$7.13M |
| 4 |
Clean Harbors
CLH
|
$6.6M |
| 5 |
Timken Company
TKR
|
$6.22M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Industrials | 46.25% |
| 2 | Healthcare | 42.59% |
| 3 | Technology | 3.29% |
| 4 | Materials | 2.86% |
| 5 | Financials | 2.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Immunocore
IMCR
$1.79B
| $330K | 0.14% |
+11,194
| New | +$330K |
|
127
Donaldson
DCI
$9.31B
| $324K | 0.13% |
+4,818
| New | +$324K |
|
128
Pinnacle West Capital
PNW
$10.6B
| $323K | 0.13% |
+3,808
| New | +$323K |
|
129
Idexx Laboratories
IDXX
$51.2B
| $304K | 0.13% |
+736
| New | +$304K |
|
130
Stryker
SYK
$151B
| $287K | 0.12% |
+798
| New | +$287K |
|
|
ITCI
131
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $283K | 0.12% |
+3,388
| New | +$283K |
|
132
Janux Therapeutics
JANX
$1.42B
| $280K | 0.12% |
+5,223
| New | +$280K |
|
133
NuScale Power
SMR
$4.96B
| $277K | 0.12% |
+15,456
| New | +$277K |
|
134
Relay Therapeutics
RLAY
$697M
| $266K | 0.11% |
+64,655
| New | +$266K |
|
135
Jasper Therapeutics
JSPR
$43.6M
| $266K | 0.11% |
+12,435
| New | +$266K |
|
136
Argan
AGX
$3.21B
| $246K | 0.1% |
+1,792
| New | +$246K |
|
137
Xenon Pharmaceuticals
XENE
$2.97B
| $240K | 0.1% |
+6,111
| New | +$240K |
|
138
CG Oncology
CGON
$2.38B
| $239K | 0.1% |
+8,329
| New | +$239K |
|
139
Catalyst Pharmaceutical
CPRX
$2.41B
| $237K | 0.1% |
+11,352
| New | +$237K |
|
140
Sarepta Therapeutics
SRPT
$1.94B
| $236K | 0.1% |
+1,943
| New | +$236K |
|
141
Tyler Technologies
TYL
$23.9B
| $235K | 0.1% |
+408
| New | +$235K |
|
142
Arvinas
ARVN
$559M
| $227K | 0.09% |
+11,835
| New | +$227K |
|
143
Becton Dickinson
BDX
$54.4B
| $209K | 0.09% |
+922
| New | +$209K |
|
144
Scholar Rock
SRRK
$3.18B
| $209K | 0.09% |
+4,836
| New | +$209K |
|
145
Acadia Pharmaceuticals
ACAD
$4.32B
| $194K | 0.08% |
+10,596
| New | +$194K |
|
146
Voyager Therapeutics
VYGR
$212M
| $84.8K | 0.04% |
+14,960
| New | +$84.8K |
|
147
Talkspace
TALK
$440M
| $81.4K | 0.03% |
+26,337
| New | +$81.4K |
|
148
Alector
ALEC
$291M
| $27.1K | 0.01% |
+14,344
| New | +$27.1K |
|